1) Strong Financial Performance
- Record sales of $818 million in Q3 2026, a 10% increase YoY, with 12% organic growth across all segments.
- Adjusted earnings per share reached $3.25, up 19% from the previous year.
- EBITDA of $262 million, representing 32% of sales, also a record for the company.
- Free cash flow of $237 million, with a conversion rate exceeding 100% of net income.

2) Segment Highlights
- Industrial Precision Solutions (IPS): Sales of $367 million, a 5% increase YoY, with organic growth of 3%. EBITDA margin held steady at 35%.
- Medical and Fluid Solutions (MFS): Achieved record sales of $231 million, with 11% organic growth. EBITDA margin improved to 38%.
- Advanced Technology Solutions (ATS): Sales reached $220 million, a 28% increase YoY, with 31% organic growth and an EBITDA margin of 30%.

3) Strategic Execution and Market Position
- The Ascend Strategy continues to drive growth, leveraging competitive advantages in differentiated products and customer relationships.
- Backlog increased by 35% YoY, indicating strong future demand and order entry momentum.
- The company is focused on maintaining high margins while pursuing growth opportunities in semiconductor and medical markets.

4) Challenges and Operational Focus
- The company is managing inflationary pressures and geopolitical factors impacting costs.
- IPS margins are stable but down YoY, reflecting a balance between growth and margin maintenance.
- Ongoing investments in innovation and operational excellence are aimed at enhancing productivity and profitability.

5) Guidance and Outlook
- Full-year sales guidance increased to $3.035 billion to $3.075 billion, with adjusted earnings expected between $11.80 and $12 per share.
- The company anticipates continued strong performance into FY 2027, particularly in ATS and MFS segments.
- M&A remains a strategic focus, with a healthy pipeline and disciplined criteria for acquisitions.

Bottom line: Nordson Corporation is demonstrating robust financial growth and operational strength, positioning itself well for continued success in the coming quarters, driven by strategic execution and a strong backlog. Shareholders can expect sustained value creation through disciplined growth and capital allocation strategies.